2002至2016年德国某地区糖尿病与非糖尿病人群肾脏替代治疗的发生率及相对风险
该回顾性人群研究分析德国某地区一家透析中心约31万居民的数据,比较糖尿病与非糖尿病人群慢性肾脏替代治疗的年龄和性别标化发生率及相对风险,并分析2002至2016年趋势。研究期间共1107人首次接受肾脏替代治疗,糖尿病人群相对风险为3.57(95%CI 3.09, 4.13),两人群发生率及相对风险在观察期内均无显著变化。
要点
- 2002至2016年共1107人首次接受肾脏替代治疗,其中48.7%患糖尿病。
- 糖尿病与非糖尿病人群肾脏替代治疗相对风险为3.57(95%CI 3.09, 4.13)。
- 观察期内两人群发生率及相对风险均无显著变化。
核心结论
- 糖尿病人群需要肾脏替代治疗的风险高于非糖尿病人群,相对风险为3.57(95%CI 3.09, 4.13),且该风险在15年观察期内保持恒定。
研究设计与样本
- 回顾性人群研究,分析德国某地区一家透析中心的数据,覆盖约31万居民,2002至2016年共1107人首次接受肾脏替代治疗(61.2%为男性,平均年龄71.6岁,48.7%患糖尿病)。
主要发现
- 糖尿病人群肾脏替代治疗发生率从2002年的93.6(95%CI 50.4, 136.7)/10万人年变化至2016年的140.5(95%CI 80.6, 200.4)/10万人年。
- 非糖尿病人群发生率明显更低,2002年为17.3(95%CI 10.9, 23.6)/10万人年,2009年为24.6(95%CI 17.5, 31.7)/10万人年。
- 糖尿病与非糖尿病人群比较的相对风险为3.57(95%CI 3.09, 4.13)。
- 观察期内糖尿病人群和非糖尿病人群的发生率均无显著变化,相对风险也保持恒定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Data on trends of end-stage renal disease among people with diabetes are lacking. We analysed the incidence of end-stage renal disease, defined as renal replacement therapy, among people with and without diabetes, and the corresponding relative risk. Moreover, we investigated time trends for the period 2002-2016. METHODS: In this retrospective population-based study we analysed data from one dialysis centre of a region in Germany covering a population of about 310,000 inhabitants. We estimated the age- and sex-standardised incidence rates for chronic renal replacement therapy among adults with and without diabetes and the corresponding relative risks. The time trend was analysed using Poisson regression models. RESULTS: Between 2002 and 2016, 1107 people (61.2% male; mean age 71.6 years; 48.7% with diabetes) had a first renal replacement therapy. During the study period, the incidence rate in the population with diabetes varied from 93.6 (95% CI 50.4, 136.7) in 2002 to 140.5 (95% CI 80.6, 200.4) in 2016 per 100,000 person-years. In the population without diabetes the incidence rate was substantially lower and reached 17.3 (95% CI 10.9, 23.6) in 2002 and 24.6 (95% CI 17.5, 31.7) in 2009. The relative risk comparing people with and without diabetes was 3.57 (95% CI 3.09, 4.13). No significant change in the incidence rates was found during the observation period, either in the population with or in the population without diabetes, and thus the relative risk also remained constant. CONCLUSIONS/INTERPRETATION: People with diabetes have a higher risk of needing renal replacement therapy than those without diabetes, a fact that remained constant over a time period of 15 years.
引用
- Narres M, Claessen H, Kvitkina T, et al. Incidence and relative risk of renal replacement therapy in people with and without diabetes between 2002 and 2016 in a German region. Diabetologia. 2019. PMID: 31865404. doi:10.1007/s00125-019-05067-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。